Emmanuel Janssen

UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium.1

Born Dec 9, 1879, died Feb 21, 1955.1

About

UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology.

Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee.

From Wikipedia’s article on Emmanuel Janssen, shared under CC BY-SA 4.0.2

Companies

Career

Occupation: businessperson.8

  • Since 1939Board member, Société Générale de Soie Artificielle par le Procédé Viscose5
  • Since 1929Chair, Compagnie Internationale pour la Fabrication Mécanique du Verre7
  • Date not recordedFounded UCB3
  • Date not recordedBoard member, Union des Fabriques Belges de Textiles Artificiels4
  • Date not recordedChief officer, Union des Fabriques Belges de Textiles Artificiels6

Jean-Christophe Tellier became the CEO of UCB in January 2015. He was succeeding Roch Doliveux, who was the CEO from 2004 until December 2014.

From Wikipedia’s article on Emmanuel Janssen (this version), CC BY-SA 4.0.

Personal life

  • BornDec 9, 1879, Brussels metropolitan area9
  • DiedFeb 21, 1955, Vence10
  • CitizenshipBelgium11